The official blog of the Lung Institute.

Lung Institute Announces New Treatment with Bone Marrow

21 Mar 2015
| Under Press | Posted by | 4 Comments
New Bone Marrow Treatment Lung Institute

Tampa, FL – This month, the Lung Institute has started treating people suffering from chronic lung diseases with stem cells extracted from their bone marrow. This treatment protocol is added to the venous (blood-derived) option offered by the Lung Institute.

The bone marrow treatments offer the highest concentration of stem cells. Since the number of stem cells harvested from a bone marrow is greater than that of the venous procedure, patients can choose a treatment option that produces the highest chance of success.

Patients are often surprised by the simplicity of these minimally invasive procedures, but with cutting-edge technology and the patient-centric clinical team at the Lung Institute, patients can rest assured that they are in good hands. Throughout the entire treatment process, patients have the opportunity to get any questions immediately answered by our knowledgeable medical staff. The Lung Institute clinical team remains in contact with patients after treatment and works together with the patient’s physician and pulmonologist to create a strong support system for the patient.

About the Lung Institute

At the Lung Institute, we are changing the lives of hundreds of people across the nation through the innovative technology of regenerative medicine. We are committed to providing patients a more effective way to address pulmonary conditions and improve quality of life. Our physicians have gained worldwide recognition for the successful application of revolutionary, minimally invasive stem cell therapy. With over a century of combined medical experience, our doctors have established a patient experience designed with the highest concern for patient safety and quality of care. For more information, visit our website at LungInstitute.com, like us on Facebook, follow us on Twitter or call us today at (800) 729-3065.


  1. David Ebner

    3 years ago


    Thanks for your comment. The price of treatment varies for each patient based on the treatments they qualify for and their specific condition. If you’d like to know what your options are and the corresponding costs, feel free to call us at (855) 313-1149.

    We look forward to hearing from you,


  2. Tina

    3 years ago

    I wish this site gave a ballpark on the price. I realize insurance isn’t going to cover this but would like to know if I can even afford to consider it.

  3. David Ebner

    3 years ago


    Unfortunately at this time, no insurance companies offer coverage for stem cell therapy to treat pulmonary conditions. Hopefully in the future, this will change.

    Thanks for your comment,


  4. Ralph Kemp

    3 years ago

    I wonder if the procedure is covered by Harvard
    Pilgrim Health Care – My Health Care Insurance Company

Your Comment

Your email address will not be published.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.